©Translational Research Center for Medical Innovation
Working together to accelerate medical innovation
Chinese and Japanese participants gathered in Chengdu to discuss advanced medicine
FEATURES
Medical technology advancing along key fronts
Disruptive strategies for treating diseases, new medical devices and big data are set to transform medical treatment
Spinal cord treatment using stem cells
After a small-scale clinical trial, a promising stem-cell treatment for spinal cord injuries is now available in Japan
Producing fit and active centenarians
TRI is striving to enliven society by harnessing the power of regenerative medicine
Collaborating against cancer
Convening for the fourth year, Japanese and Taiwanese academics continue to push forward together to tackle critical medical science issues.
Casting a wider net for big data benefits
Embracing big data promises to expand the knowledge brought by clinical trials and lead to safer therapies
Launching a wealth of medical knowledge
An authoritative source of medical information for almost 120 years, the MSD manuals are now freely available online in Japanese
Living well to a hundred and beyond
The public were given a preview of therapies that promise to preserve the quality of life of people well into old age
The harmony of standardized data
Translational and clinical research is hampered by the ‘dissonant notes’ of poor efficacy systems and a lack of data standards, claim researchers and policymakers. Fixing these problems can save lives.
Stem cell therapies demonstrating their potential
CD34 positive stem cells could be used to treat a wide range of medical conditions
Clinical trials on trial
Poor standards in clinical trials waste time and money, and cost lives. Global cooperation is the only way to raise the bar.
From lab to clinic
TRI director Masanori Fukushima says considering disease mechanisms are the key to providing medicines to ease the journey into old age